logo

Alpine Immune Sciences Inc (ALPN) Stock: A Year of Market Movement, Down and Up

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Alpine Immune Sciences Inc’s current trading price is -10.14% away from its 52-week high, while its distance from the 52-week low is 474.22%. The stock’s price range over this period has fluctuated between $6.71 and $42.88. The company, operating within the financial sector, had a trading volume of approximately 2.59 million for the day, which was noticeably higher than the average daily share volume of 1.19 million over the last 3 months.

Alpine Immune Sciences Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $42.88 on 03/21/24, while the lowest value for the same period was recorded at $6.71 on 05/04/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Alpine Immune Sciences Inc (ALPN) has experienced a quarterly rise of 117.07% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.53B and boasts a workforce of 142 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 25.69, with a change in price of +26.31. Similarly, Alpine Immune Sciences Inc recorded 1,030,558 in trading volume during the last 100 days, posting a change of +215.30%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ALPN stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.

ALPN Stock Stochastic Average

Today, Alpine Immune Sciences Inc’s raw stochastic average for the past 50 days stands at 79.25%, indicating a rise from the raw stochastic average of the last 20 days, which was 49.59%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 22.83% and 26.07% respectively.

ALPN Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price gain of 102.15% this year. Over the last six months, there has been a weaker performance of 216.08%. The price of ALPN fallen by 4.14% during the last 30 days period. For the last 5-days stocks have slided -4.20%.